Board of Directors

Andrew Hedin

Andrew Hedin is an investor in Bessemer’s Cambridge office where he focuses on investments in biotechnology and healthcare.

Prior to joining Bessemer in 2015, Andrew worked at F-Prime Capital, Fidelity’s healthcare-focused venture capital fund, as well as Leerink Partners as an advisor to biopharma clients.

He earned an MBA with honors from The Wharton School, where he majored in health care management and finance, as well as a degree in biological basis of behavior from the University of Pennsylvania.